Forex
Swiss National Bank Boosts Holdings in Praxis Precision Medicines
Swiss National Bank has increased its holdings in Praxis Precision Medicines by 15.3% during the first quarter, according to a recent disclosure with the SEC.
The bank purchased an additional 6,200 shares of the company's stock, bringing its total holdings to 46,700 shares worth approximately $15 million at the end of the quarter.
Swiss National Bank now owns about 0.17% of Praxis Precision Medicines' outstanding shares.
Other institutional investors and hedge funds have also made changes to their positions in the company during the fourth quarter, including Orbis Allan Gray Ltd, Janus Henderson Group PLC, Barclays PLC, Baker BROS. Advisors LP, and Perceptive Advisors LLC.